Created in 2008 (United States), Ra Pharmaceuticals own 359 sister brands and 2214 competing brands. Ra Pharmaceuticals is owned by UCB, listed on the stock exchange of Bruxelles The International Securities Identification Number (ISIN) of UCB is BE0003739530. Ra Pharmaceuticals is part of the Biotechnology activity sector.